My Wish Lists Login / Join

Interleukin 12

Antitumor Activity and Immunotherapeutic Potential in Oncology

By: Witold Lasek, Radoslaw Zagozdzon, Marek JakÃ³bisiak (Contribution by)

Write A Review

Paperback | 6 October 2016

At a Glance

Paperback
84 Pages

Dimensions(cm)
23.39 x 15.6 x 0.43

Paperback

$146.75

or 4 interest-free payments of $36.69 with

Ships in 10 to 15 business days

This book discusses the immunotherapeutic potential of Interleukin 12 in the context of clinical oncology, as well as antitumor effects confirmed in preclinical studies and clinical trials in cancer immunotherapy. Due to its ability to activate both innate (NK cells) and adaptive (cytotoxic T lymphocytes) immunities, Interleukin 12 (IL-12) has been regarded as a promising candidate for tumor immunotherapy. However, despite the encouraging results in animal models, only very modest antitumor effects have been confirmed in early clinical trials. Recently, several clinical studies have been initiated in which IL-12 was applied as an adjuvant in cancer vaccines, in gene therapy including locoregional injections of IL-12 plasmid, and in the form of tumor-targeting immunocytokines (IL-12 fused to monoclonal antibodies).

Shipping

	Standard Shipping	Express Shipping
Metro postcodes:	$9.99	$14.95
Regional postcodes:	$9.99	$14.95
Rural postcodes:	$9.99	$14.95

How to return your order

At Booktopia, we offer hassle-free returns in accordance with our returns policy. If you wish to return an item, please get in touch with Booktopia Customer Care.

Additional postage charges may be applicable.